- Home
- CUE vs NCMI Comparison
CUE vs NCMI Comparison
Compare CUE & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | NCMI |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.0M | 207.0M |
| IPO Year | 2017 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CUE | NCMI |
|---|---|---|
| Price | $21.97 | $1.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $88.00 | $4.44 |
| AVG Volume (30 Days) | 153.2K | ★ 726.1K |
| Earning Date | 11-11-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ 61.11 | 52.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | $9.27 |
| Revenue Next Year | N/A | $2.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $1.73 |
| 52 Week High | $45.50 | $4.51 |
Technical Indicators
Market Signals| Indicator | CUE | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 24.37 |
| Support Level | $17.06 | N/A |
| Resistance Level | $33.95 | $2.30 |
| Average True Range (ATR) | 2.33 | 0.10 |
| MACD | 0.45 | -0.02 |
| Stochastic Oscillator | 41.30 | 4.67 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.